Letrozol STADA 2.5mg

Letrozol STADA is a generic pharmaceutical product used primarily in the treatment of hormone-responsive breast cancer in postmenopausal women. The brand is managed by STADA Arzneimittel AG, a major international pharmaceutical company.

STADA specializes in the production of generic drugs and consumer healthcare products. While the brand has deep German roots, its manufacturing operations are spread across Europe and other global regions to serve international markets. The company maintains a strong corporate presence in Spain through its subsidiary, STADA España, which handles the distribution and registration of its medical portfolio within the Spanish healthcare system.